Radiotherapy enhances triple therapy for conversion and survival in patients with unresectable hepatocellular carcinoma with portal vein tumor thrombus
BioScience Trends · 2025
DOI: 10.5582/bst.2025.01170 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioScience Trends, 2025. Verfasst von Ying Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Portal Vein, Chemoembolization, Therapeutic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Liver Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China.
- Chinese Evidence-based Medicine Center and CREAT Group, West China Hospital, Sichuan University, Chengdu, China.
Zitieren
APA
Zhou, Y., Yao, M., Wen, T., & Li, C. (2025). Radiotherapy enhances triple therapy for conversion and survival in patients with unresectable hepatocellular carcinoma with portal vein tumor thrombus. BioScience Trends. https://doi.org/10.5582/bst.2025.01170
Vancouver
Zhou Y, Yao M, Wen T, Li C. Radiotherapy enhances triple therapy for conversion and survival in patients with unresectable hepatocellular carcinoma with portal vein tumor thrombus. BioScience Trends. 2025. doi:10.5582/bst.2025.01170
BibTeX
@article{Zhou2025,
author = {Zhou, Ying and Yao, Minghong and Wen, Tianfu and Li, Chuan},
title = {Radiotherapy enhances triple therapy for conversion and survival in patients with unresectable hepatocellular carcinoma with portal vein tumor thrombus},
journal = {BioScience Trends},
year = {2025},
doi = {10.5582/bst.2025.01170}
}
EUVIMED